S. Yahng

发表

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2011, Leukemia & lymphoma.

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

S. Lee, S. Lee, A. Kwon, 2015, Bone Marrow Transplantation.

Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2012, Annals of Hematology.

Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1–RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1–RUNX1T1

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, Cancers.

WT1 measurable residual disease assay in AML who underwent allogeneic hematopoietic stem cell transplantation; optimal time points, threshold, and candidates.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Annals of Hematology.

Comparison of transplant‐specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, European journal of haematology.

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma

S. Jung, J. O, K. Eom, 2020, Diagnostics.

The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, The Korean journal of internal medicine.

Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma.

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2012, Cytotherapy.

Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Blood research.

A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Cancers.

Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population

Dong-Wook Kim, Soo-hyun Kim, Sung‐Eun Lee, 2014, International Journal of Hematology.

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

Sung-Soo Yoon, S. Oh, W. Lee, 2014, American journal of clinical oncology.

Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2020, American journal of hematology.

Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2012, Acta Haematologica.

Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Annals of Hematology.

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

S. Lee, Y. Kim, Y. Kim, 2015, Bone Marrow Transplantation.

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia

J. W. Lee, S. Lee, Y. Kim, 2016, Bone Marrow Transplantation.

Survival benefits from reduced‐intensity conditioning in allogeneic stem cell transplantation for young lower‐risk MDS patients without significant comorbidities

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2011, European journal of haematology.

Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Cancers.

Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2013, International Journal of Hematology.

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

S. Lee, Y. Kim, H. Kim, 2014, Bone Marrow Transplantation.

A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML)

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Therapeutic advances in hematology.

Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2014, Hematology.

Role of pretransplant anti‐thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, European journal of haematology.

Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma

C. Min, Sung‐Eun Lee, S. Yahng, 2012, Immune network.

The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Annals of Hematology.

Non‐myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, European journal of haematology.

Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2021, Bone Marrow Transplantation.

Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients.

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2021, Transplantation and cellular therapy.

Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes.

Yoo-Jin Kim, Inho Kim, Sung‐Eun Lee, 2012, Leukemia research.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, European journal of haematology.

Erdheim-Chester disease with lung involvement mimicking pulmonary lymphangitic carcinomatosis.

B. Lee, S. H. Lee, H. Kang, 2009, The American journal of the medical sciences.

Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, Therapeutic advances in hematology.

Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ocular manifestations of idiopathic aplastic anemia: retrospective study and literature review

A. Mansour, N. Hamerschlak, M. Shahin, 2014, Clinical ophthalmology.

SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2015, Blood research.

Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, Bone Marrow Transplantation.

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome

Jongtae Lee, D. Yim, Yoo-Jin Kim, 2015, Journal of Hematology & Oncology.

Equivalent Outcome of Autologous Stem Cell Transplantation and Reduced Intensity Conditioning Stem Cell Transplantation in Acute Myeloid Leukemia Patients with t(8;21)

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Acta Haematologica.

Reduced-Intensity Conditioning Regimen Combined with Low-Dose Total Body Irradiation in the Treatment of Myelodysplastic Syndrome

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2011, Acta Haematologica.

Novel Markers of Early Neutrophilic and Monocytic Engraftment after Hematopoietic Stem Cell Transplantation

Jae Wook Lee, J. Kahng, Yonggoo Kim, 2014, Annals of laboratory medicine.

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Blood research.

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

S. Lee, Y. Kim, Y. Kim, 2012, Leukemia.

New Proposed Guidelines for Early Identification of Successful Myeloid and Erythroid Engraftment in Hematopoietic Stem Cell Transplantation

Jae Wook Lee, Yonggoo Kim, J. Lee, 2014, Journal of clinical laboratory analysis.

Risk and prognostic factors for acute GVHD based on NIH consensus criteria

Y. Kim, H. Kim, D-W. Kim, 2013, Bone Marrow Transplantation.

Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2010, Transplantation.

Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.

Yoo-Jin Kim, Jae‐Ho Yoon, Jung-Ho Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA‐matched sibling donor

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2021, American journal of hematology.

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

J. W. Lee, H. Kim, S. Lee, 2016, Bone Marrow Transplantation.

Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2014, Leukemia & lymphoma.

Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2014, Hematological oncology.

BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core‐binding‐factor‐positive AML

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Prediction Model for Second Allogeneic Stem‐Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single‐Center Report

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2018, Clinical lymphoma, myeloma & leukemia.

Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts

Yoo-Jin Kim, Jae‐Ho Yoon, Dong-Wook Kim, 2016, Oncotarget.

Second Primary Glioblastoma Multiforme Following Autologous Hematopoietic Stem Cell Transplantation in a Patient with Acute Myelogenous Leukemia

B. Cho, W. Min, Hee‐Je Kim, 2011, Cancer research and treatment : official journal of Korean Cancer Association.

Geriatric assessment predicts non-fatal toxicities and survival for intensively treated older adults with AML.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Blood.

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.

Tae Woo Kim, B. Cho, Jae‐Ho Yoon, 2018, International Journal of Stem Cells.

Comparable long‐term outcomes after reduced‐intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high‐risk acute lymphoblastic leukemia in complete remission

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, American journal of hematology.

Influence of ex vivo purging with CliniMACS CD34+ selection on outcome after autologous stem cell transplantation in non‐Hodgkin lymphoma

Seung-Hwan Shin, Jae-Ho Yoon, Seok Lee, 2014, British journal of haematology.

Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia.

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

S. Lee, Y. Kim, H. Kim, 2013, Bone Marrow Transplantation.

The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2013, Blood research.

Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome

Y. Kim, H. Kim, C. Min, 2017, Bone Marrow Transplantation.

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

Y. Kim, H. Kim, D-W. Kim, 2013, Bone Marrow Transplantation.

Outcomes of elderly de novo acute myeloid leukemia treated by a risk‐adapted approach based on age, comorbidity, and performance status

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, American journal of hematology.

Superior transplantation outcomes of 8/8‐matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2013, European journal of haematology.

Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma

B. Cho, Yoo-Jin Kim, Dong-Wook Kim, 2011, European journal of haematology.

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia

Tae Woo Kim, B. Cho, Jae‐Ho Yoon, 2018, International journal of stem cells.

Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.

Yonggoo Kim, B. Cho, Yoo-Jin Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Bone Marrow Transplantation.

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2020, Annals of Hematology.

Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study

Sun U. Song, Jun Hyung Kim, C. Min, 2015, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

D. Dingli, C. Min, S. Yahng, 2023, NPJ precision oncology.

Response and dynamics of renal function for transplant-eligible multiple myeloma patients who were treated with novel agent: The CAREMM-2201 study.

Yaeni Kim, C. Min, S. Yahng, 2022, Transplantation and cellular therapy.

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2022, Frontiers in Oncology.

Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study

C. Min, S. Yahng, Y. Jeon, 2023, Journal of Cancer Research and Clinical Oncology.

Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy

B. Cho, Yoo-Jin Kim, Jae‐Ho Yoon, 2017, Oncotarget.